Showing results (1661-1670 of 1,745) with videos related to

Sort By:
Pageof 175
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Acidity across the interface from the ocean surface to sea spray aerosolKyle J Angle, Daniel R Crocker, Rebecca M C Simpson, et al.
Journal of the National Cancer Institute|October 12, 2021
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405Marla Lipsyc-Sharf, Sui Zhang, Fang-Shu Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance)En Cheng, Fang-Shu Ou, Chao Ma, et al.
JAMA Network Open|August 31, 2021
Evaluation of Dietary Patterns and All-Cause Mortality: A Systematic ReviewLaural K English, Jamy D Ard, Regan L Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144Stephen R Smalley, Jacqueline K Benedetti, Stephen K Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2005
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyRoy S Herbst, Dean F Bajorin, Harry Bleiberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)Charles S Fuchs, Donna Niedzwiecki, Harvey J Mamon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2025
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)Francesca Battaglin, Bert H O'Neil, Sebastian Stintzing, et al.
Blood Cancer Journal|January 16, 2016
Karyotype complexity and prognosis in acute myeloid leukemiaF Stölzel, B Mohr, M Kramer, et al.
Pageof 175